{"id":"https://openalex.org/W7220905076","doi":"https://doi.org/10.3389/fonc.2026.1896692","title":"Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and PD-1 inhibitors for unresectable hepatocellular carcinoma: a meta-analysis","display_name":"Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and PD-1 inhibitors for unresectable hepatocellular carcinoma: a meta-analysis","publication_year":2026,"publication_date":"2026-10-08","ids":{"openalex":"https://openalex.org/W7220905076","doi":"https://doi.org/10.3389/fonc.2026.1896692","pmid":"https://pubmed.ncbi.nlm.nih.gov/42923097","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13686884"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1896692","doi":"https://doi.org/10.3389/fonc.2026.1896692","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1896692","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1896692/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1896692/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051860391","display_name":"Renbin Ouyang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162246","display_name":"Loudi Central Hospital","ror":"https://ror.org/04jref587","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210162246"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Renbin Ouyang","raw_affiliation_strings":["Department of Hepatobiliary Surgery, Loudi Central Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary Surgery, Loudi Central Hospital","institution_ids":["https://openalex.org/I4210162246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032667940","display_name":"Xiaocheng Li","orcid":"https://orcid.org/0000-0002-9425-564X","observed_orcids":["https://orcid.org/0000-0002-9425-564X"]},"institutions":[{"id":"https://openalex.org/I4210097509","display_name":"Second Affiliated Hospital of Chongqing Medical University","ror":"https://ror.org/00r67fz39","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210097509"]},{"id":"https://openalex.org/I4210162246","display_name":"Loudi Central Hospital","ror":"https://ror.org/04jref587","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210162246"]},{"id":"https://openalex.org/I4405281344","display_name":"Hunan University of Medicine","ror":"https://ror.org/047sgsy47","country_code":"CN","type":"education","lineage":["https://openalex.org/I4405281344"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xiaocheng Li","raw_affiliation_strings":["Department of Hepatobiliary Surgery, Loudi Central Hospital","Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan University of Medicine","Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary Surgery, Loudi Central Hospital","institution_ids":["https://openalex.org/I4210162246"]},{"raw_affiliation_string":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan University of Medicine","institution_ids":["https://openalex.org/I4405281344"]},{"raw_affiliation_string":"Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University","institution_ids":["https://openalex.org/I4210097509"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159662686","display_name":"Kun Huang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kun Huang","raw_affiliation_strings":["Department of General Surgery, The People\u2019s Hospital of Liangping District"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Surgery, The People\u2019s Hospital of Liangping District","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159597728","display_name":"Duke Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I158842170","display_name":"Chongqing University","ror":"https://ror.org/023rhb549","country_code":"CN","type":"education","lineage":["https://openalex.org/I158842170"]},{"id":"https://openalex.org/I4210154480","display_name":"Chongqing Cancer Hospital","ror":"https://ror.org/047d8yx24","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154480"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Duke Chen","raw_affiliation_strings":["Department of Gynecologic Oncology, Chongqing University Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecologic Oncology, Chongqing University Cancer Hospital","institution_ids":["https://openalex.org/I158842170","https://openalex.org/I4210154480"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045932625","display_name":"Yaowei Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87780372","display_name":"Chongqing Medical University","ror":"https://ror.org/017z00e58","country_code":"CN","type":"education","lineage":["https://openalex.org/I87780372"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yaowei Yang","raw_affiliation_strings":["Department of General Surgery, University-Town Hospital of Chongqing Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Surgery, University-Town Hospital of Chongqing Medical University","institution_ids":["https://openalex.org/I87780372"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159724760","display_name":"Xinmin Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097509","display_name":"Second Affiliated Hospital of Chongqing Medical University","ror":"https://ror.org/00r67fz39","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210097509"]},{"id":"https://openalex.org/I4210162246","display_name":"Loudi Central Hospital","ror":"https://ror.org/04jref587","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210162246"]},{"id":"https://openalex.org/I4405281344","display_name":"Hunan University of Medicine","ror":"https://ror.org/047sgsy47","country_code":"CN","type":"education","lineage":["https://openalex.org/I4405281344"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xinmin Li","raw_affiliation_strings":["Department of Hepatobiliary Surgery, Loudi Central Hospital","Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan University of Medicine","Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary Surgery, Loudi Central Hospital","institution_ids":["https://openalex.org/I4210162246"]},{"raw_affiliation_string":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan University of Medicine","institution_ids":["https://openalex.org/I4405281344"]},{"raw_affiliation_string":"Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University","institution_ids":["https://openalex.org/I4210097509"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063655314","display_name":"\u6731\u4e3d\u660e","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I4210097066","display_name":"Shanghai Ninth People's Hospital","ror":"https://ror.org/010826a91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210097066"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Liming Zhu","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210097066"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5115662829","display_name":"\u6625\u77e5 \u6881","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405281344","display_name":"Hunan University of Medicine","ror":"https://ror.org/047sgsy47","country_code":"CN","type":"education","lineage":["https://openalex.org/I4405281344"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Chunzhi Liang","raw_affiliation_strings":["Department of Hematology and Oncology, The First Affiliated Hospital of Hunan University of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, The First Affiliated Hospital of Hunan University of Medicine","institution_ids":["https://openalex.org/I4405281344"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5032667940","https://openalex.org/A5063655314","https://openalex.org/A5115662829"],"corresponding_institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210097066","https://openalex.org/I4210097509","https://openalex.org/I4210162246","https://openalex.org/I4405281344"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.51451058,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1896692","last_page":"1896692"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/unresectable-hepatocellular-carcinoma","display_name":"unresectable hepatocellular carcinoma","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hepatic-arterial-infusion-chemotherapy","display_name":"hepatic arterial infusion chemotherapy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/dual-therapy","display_name":"dual therapy","score":0.5690000057220459},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8389999866485596},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.9509999752044678},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.9240000247955322},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.9739999771118164},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.9399999976158142},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7440000176429749},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5440000295639038},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.4560000002384186},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8910999894142151},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.6884999871253967},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.661899983882904},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.613099992275238},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5961999893188477},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5791000127792358},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5619999766349792},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5205000042915344},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.513700008392334},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4799000024795532},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4722999930381775},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4334999918937683},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.4325000047683716},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4284999966621399},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.39480000734329224},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3944000005722046},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38019999861717224},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.3625999987125397},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.3370000123977661},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.3264999985694885},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3075000047683716},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.30379998683929443},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.29820001125335693},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2980000078678131},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.2766999900341034},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2703000009059906},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.258899986743927},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.25049999356269836}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.1896692","doi":"https://doi.org/10.3389/fonc.2026.1896692","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1896692","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1896692/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13686884","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13686884/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13686884/pdf/fonc-16-1896692.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:42923097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42923097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b8038cda3bea459c9ba225767756597b","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b8038cda3bea459c9ba225767756597b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1896692","doi":"https://doi.org/10.3389/fonc.2026.1896692","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1896692","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1896692/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220905076.pdf","grobid_xml":"https://content.openalex.org/works/W7220905076.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W2032506622","https://openalex.org/W2039418122","https://openalex.org/W2098841709","https://openalex.org/W2119605658","https://openalex.org/W2125435699","https://openalex.org/W2156098321","https://openalex.org/W2157823046","https://openalex.org/W2166025830","https://openalex.org/W2562159002","https://openalex.org/W2885675882","https://openalex.org/W3025022288","https://openalex.org/W3113665313","https://openalex.org/W3134644767","https://openalex.org/W3204245666","https://openalex.org/W3204422329","https://openalex.org/W3205893412","https://openalex.org/W4200240365","https://openalex.org/W4200388794","https://openalex.org/W4281645619","https://openalex.org/W4283077906","https://openalex.org/W4297383945","https://openalex.org/W4311974397","https://openalex.org/W4323812364","https://openalex.org/W4324148985","https://openalex.org/W4327571871","https://openalex.org/W4363674133","https://openalex.org/W4378347345","https://openalex.org/W4385172611","https://openalex.org/W4391028899","https://openalex.org/W4392938370","https://openalex.org/W4393316215","https://openalex.org/W4394847424","https://openalex.org/W4399739420","https://openalex.org/W4399879175","https://openalex.org/W4400273495","https://openalex.org/W4400583267","https://openalex.org/W4401792596","https://openalex.org/W4402384210","https://openalex.org/W4402537367","https://openalex.org/W4402560759","https://openalex.org/W4411253128","https://openalex.org/W4412634163","https://openalex.org/W4412720352","https://openalex.org/W4415746551","https://openalex.org/W7125430056"],"related_works":["https://openalex.org/W4411146447","https://openalex.org/W4401792596","https://openalex.org/W4391241456","https://openalex.org/W4297383945","https://openalex.org/W4322765869","https://openalex.org/W4281298900","https://openalex.org/W4408956760","https://openalex.org/W4401525010","https://openalex.org/W4389609185","https://openalex.org/W4388021309"],"abstract_inverted_index":{"Background":[0],"The":[1,97,116,288],"triplet":[2],"combination":[3],"of":[4,44,51,149,227,236,256,282],"hepatic":[5],"arterial":[6],"infusion":[7],"chemotherapy":[8],"(HAIC),":[9],"a":[10,16,25,52,55,80,83,88,91,195],"tyrosine":[11],"kinase":[12],"inhibitor":[13,21,85,93],"(TKI),":[14],"and":[15,42,64,82,111,181,206,259,285,297],"programmed":[17],"cell":[18],"death-1":[19],"(PD-1)":[20],"has":[22],"emerged":[23],"as":[24],"highly":[26],"promising":[27],"strategy":[28],"for":[29,68,95,267],"unresectable":[30],"hepatocellular":[31],"carcinoma":[32],"(uHCC).":[33],"This":[34],"study":[35],"aimed":[36],"to":[37,129,277],"comprehensively":[38],"evaluate":[39],"the":[40,49,65,164,191,224,234,244,271],"efficacy":[41],"safety":[43],"this":[45],"triple-therapy":[46,245,273],"compared":[47],"with":[48,140,155,160,170,269],"dual-therapy":[50],"TKI":[53,81,89],"plus":[54,79,90],"PD-1":[56,84,92],"inhibitor.":[57],"Methods":[58],"We":[59],"systematically":[60],"searched":[61],"PubMed,":[62],"Embase,":[63],"Cochrane":[66],"Library":[67],"randomized":[69],"controlled":[70],"trials":[71],"or":[72,136],"comparative":[73],"cohort":[74],"studies":[75,151],"that":[76,266],"assessed":[77],"HAIC":[78],"(H-T-P)":[86],"versus":[87],"(T-P)":[94],"uHCC.":[96],"primary":[98],"endpoints":[99],"were":[100,157],"overall":[101,225],"survival":[102,105,283],"(OS),":[103],"progression-free":[104],"(PFS),":[106],"objective":[107],"response":[108],"rate":[109,114],"(ORR),":[110],"disease":[112],"control":[113],"(DCR).":[115],"secondary":[117],"endpoint":[118],"was":[119,127,168,221,240],"treatment-related":[120],"adverse":[121],"events":[122],"(AEs).":[123],"A":[124,147],"random-effects":[125],"model":[126],"employed":[128],"pool":[130],"data,":[131],"calculating":[132],"hazard":[133],"ratios":[134],"(HRs)":[135],"relative":[137],"risks":[138],"(RRs)":[139],"their":[141],"95%":[142],"confidence":[143],"intervals":[144],"(CIs).":[145],"Results":[146],"total":[148],"12":[150],"involving":[152],"2,386":[153],"patients":[154,268],"uHCC":[156],"included.":[158],"Compared":[159],"T-P":[161],"dual":[162,278],"therapy,":[163],"H-T-P":[165,192,272],"triple":[166],"therapy":[167,279],"associated":[169,289],"significantly":[171,196,241],"improved":[172],"OS":[173],"(HR,":[174,183],"0.51;":[175],"95%CI,":[176,185,201,210,249],"0.47-0.56;":[177],"P":[178,187,203,212,231,251],"<":[179,188,204,213],"0.001)":[180,205],"PFS":[182],"0.59;":[184],"0.51-0.68;":[186],"0.001).":[189,214],"Furthermore,":[190],"group":[193],"demonstrated":[194],"higher":[197,242],"ORR":[198],"(RR,":[199,208,247],"1.97;":[200],"1.73-2.24;":[202],"DCR":[207],"1.19;":[209],"1.11-1.28;":[211],"Regarding":[215],"safety,":[216],"while":[217],"no":[218],"significant":[219],"difference":[220],"observed":[222],"in":[223,243,280,291],"incidence":[226,235],"all-grade":[228],"AEs":[229,239],"(":[230],"=":[232,252],"0.238),":[233],"grade":[237],"\u22653":[238],"arm":[246],"1.29;":[248],"1.13-1.48;":[250],"0.004),":[253],"consisting":[254],"primarily":[255],"manageable":[257],"hepatotoxicity":[258],"hematologic":[260],"toxicities.":[261],"Conclusion":[262],"Our":[263],"findings":[264],"indicate":[265],"uHCC,":[270],"regimen":[274],"is":[275,294],"superior":[276],"terms":[281],"benefits":[284],"tumor":[286],"response.":[287],"increase":[290],"severe":[292],"toxicity":[293],"considered":[295],"predictable":[296],"clinically":[298],"manageable.":[299],"Systematic":[300],"Review":[301],"Registration":[302],"https://www.crd.york.ac.uk/PROSPERO/":[303],",":[304],"identifier":[305],"CRD420251113276.":[306]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-09T00:00:00"}